Keybanc Maintains Overweight on Steris, Raises Price Target to $254
Portfolio Pulse from richadhand@benzinga.com
Keybanc analyst Matthew Mishan maintains an Overweight rating on Steris (NYSE:STE) and raises the price target from $235 to $254.
July 25, 2023 | 8:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc analyst maintains an Overweight rating on Steris and raises the price target from $235 to $254.
The raised price target by Keybanc analyst indicates a positive outlook for Steris. This could potentially lead to an increase in the stock price in the short term as it suggests that the stock is undervalued at its current price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100